Mouse PD-L1 / B7-H1 Protein, His Tag (MALS verified)
分子別名(Synonym)
PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Mouse PD-L1, His Tag (PD1-M5220) is expressed from human 293 cells (HEK293). It contains AA Phe 19 - Thr 238 (Accession # NP_068693).
Predicted N-terminus: Phe 19
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 26.6 kDa. The protein migrates as 40-50 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
程序性細(xì)胞死亡1配體1(PDL1)也被稱為B7-H、B7H1、MGC142294、MGC142266、PD-L1、PDCD1L1和PDCD1LG1,它是不斷增長(zhǎng)的B7免疫分子家族的成員,參與細(xì)胞和體液免疫反應(yīng)的調(diào)節(jié)。PDL1是一個(gè)細(xì)胞表面免疫球蛋白超家族,在細(xì)胞外區(qū)域有兩個(gè)Ig樣結(jié)構(gòu)域和一個(gè)短的細(xì)胞質(zhì)結(jié)構(gòu)域。這種蛋白質(zhì)在大多數(shù)外周組織和造血細(xì)胞中廣泛表達(dá)。PDL1與其屬于CD28家族的受體之間的相互作用在調(diào)節(jié)T細(xì)胞活化和耐受方面提供了刺激和抑制信號(hào)。PDL1可能通過誘導(dǎo)細(xì)胞凋亡和阻止細(xì)胞周期進(jìn)程來抑制正在進(jìn)行的T細(xì)胞反應(yīng)。
關(guān)鍵字: PD-L1;PD-L1蛋白;PD-L1重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。